Emergent Biosolutions Inc. Operating Cash Flow

Operating Cash Flow of EBS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Cash Flow growth rates and interactive chart. Operating cash flow (OCF) is a measure of the amount of cash generated by a company's normal business operations. Operating cash flow indicates whether a company can generate sufficient positive cash flow to maintain and grow its operations, otherwise it may require external financing for expansion or even survival. A negative number means the company is funded through external capital (debt or equity issuance) or cash available on the balance sheet. A positive number means that a company generates enough cash to pay for its operations.

Highlights and Quick Summary

  • Operating Cash Flow for the quarter ending June 30, 2023 was $-114 Million (a -37.83% decrease compared to previous quarter)
  • Year-over-year quarterly Operating Cash Flow increased by 54.59%
  • Annual Operating Cash Flow for 2022 was $-34.1 Million (a -110.62% decrease from previous year)
  • Annual Operating Cash Flow for 2021 was $321 Million (a -40.09% decrease from previous year)
  • Annual Operating Cash Flow for 2020 was $536 Million (a 185.11% increase from previous year)
  • Twelve month Operating Cash Flow ending June 30, 2023 was $-280 Million (a 54.65% increase compared to previous quarter)
  • Twelve month trailing Operating Cash Flow decreased by -238.35% year-over-year
Trailing Operating Cash Flow for the last four month:
30 Jun '23 31 Mar '23 31 Dec '22 30 Sep '22
$-280 Million $-181 Million $-34.1 Million $202 Million
Visit stockrow.com/EBS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Cash Flow of Emergent Biosolutions Inc.

Most recent Operating Cash Flowof EBS including historical data for past 10 years.

Interactive Chart of Operating Cash Flow of Emergent Biosolutions Inc.

Emergent Biosolutions Inc. Operating Cash Flow for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $-114.4 $-184.0 – – –
2022 $92.8 $-74.0 $-15.6 $-37.3 $-34.1
2021 $329.0 $16.7 $-29.7 $5.1 $321.1
2020 $245.1 $105.2 $127.9 $57.8 $536.0
2019 $122.1 $-3.1 $-35.8 $104.8 $188.0
2018 $-165.8 $174.0 $34.6 $-1.0 $41.8
2017 $77.49 $34.94 $54.0 $41.67 $208.1
2016 $-12.65 $27.08 $-2.0 $42.17 $54.6
2015 $1.13 $104.76 $2.5 $-65.87 $42.52
2014 $51.82 $78.92 $10.82 $-29.25 $112.32
2013 $8.64 $60.13 $32.83 $-4.63 $96.97
2012 $-39.02 – – – $39.64

Business Profile of Emergent Biosolutions Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com